4971 - 4980 of 6078 Results
Title
Year
-
OPENTitle: Regulation of Memory Formation by the Transcription Factor XBP1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 1382End Page: 1394Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2016.01.028Best OA location URL: http://www.cell.com/article/S2211124716000498/pdfCitation Count: 154
-
OPENTitle: Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working MemoryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 9Start Page: 2224End Page: 2231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2016.14Best OA location URL: https://www.nature.com/articles/npp201614.pdfCitation Count: 27
-
OPENTitle: Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000193Best OA location URL: https://nn.neurology.org/content/nnn/3/1/e193.full.pdfCitation Count: 15
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016OPENTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://doi.org/10.7554/elife.12813Citation Count: 925
-
OPENTitle: Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson DiseaseJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 97Issue #: 5Start Page: 665End Page: 673Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2015.12.029Best OA location URL: https://europepmc.org/articles/pmc4844795?pdf=renderCitation Count: 45
- Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings2016OPENTitle: Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy FindingsJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 2Start Page: 250End Page: 256Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26476Best OA location URL: https://europepmc.org/articles/pmc4747813?pdf=renderCitation Count: 76
-
OPENTitle: Clinical signs in functional (psychogenic) gait disorders: a brief surveyJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0031-1Best OA location URL: https://doi.org/10.1186/s40734-016-0031-1Citation Count: 22
-
OPENTitle: Mood Differences Among Parkinson’s Disease Patients With Mild Cognitive ImpairmentJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 28Issue #: 3Start Page: 211End Page: 216Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.15090221Best OA location URL: https://neuro.psychiatryonline.org/doi/pdf/10.1176/appi.neuropsych.15090221Citation Count: 30
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 233
-
OPENTitle: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 173Issue #: 5Start Page: 465End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2015.15050648Citation Count: 86